Short Interest in Kewaunee Scientific Corporation (NASDAQ:KEQU) Rises By 66.4%

Kewaunee Scientific Corporation (NASDAQ:KEQU) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totaling 35,595 shares, a growth of 66.4% from the November 30th total of 21,397 shares. Based on an average daily trading volume, of 8,858 shares, the short-interest ratio is presently 4.0 days. Approximately 1.4% of the company’s shares are short sold. Approximately 1.4% of the company’s shares are short sold. Based on an average daily trading volume, of 8,858 shares, the short-interest ratio is presently 4.0 days.

Insiders Place Their Bets

In other news, VP Elizabeth D. Phillips sold 6,880 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $43.20, for a total value of $297,216.00. Following the transaction, the vice president owned 8,248 shares of the company’s stock, valued at $356,313.60. This represents a 45.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Donald T. Gardner III sold 3,000 shares of the firm’s stock in a transaction dated Thursday, October 9th. The stock was sold at an average price of $42.76, for a total value of $128,280.00. Following the transaction, the chief financial officer owned 11,564 shares in the company, valued at approximately $494,476.64. This trade represents a 20.60% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 11,880 shares of company stock valued at $507,586. Company insiders own 13.30% of the company’s stock.

Institutional Trading of Kewaunee Scientific

A number of large investors have recently bought and sold shares of the business. Bank of America Corp DE boosted its holdings in Kewaunee Scientific by 2,605.9% in the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after buying an additional 443 shares during the period. American Century Companies Inc. lifted its position in shares of Kewaunee Scientific by 43.4% during the first quarter. American Century Companies Inc. now owns 49,182 shares of the technology company’s stock worth $1,937,000 after acquiring an additional 14,889 shares in the last quarter. OMERS ADMINISTRATION Corp bought a new position in shares of Kewaunee Scientific in the first quarter worth $284,000. Punch & Associates Investment Management Inc. purchased a new position in shares of Kewaunee Scientific in the first quarter valued at $788,000. Finally, Goldman Sachs Group Inc. raised its stake in shares of Kewaunee Scientific by 125.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 19,397 shares of the technology company’s stock valued at $764,000 after purchasing an additional 10,803 shares during the period. 32.69% of the stock is currently owned by institutional investors and hedge funds.

Kewaunee Scientific Price Performance

Shares of KEQU traded up $0.09 during trading hours on Tuesday, reaching $37.74. The stock had a trading volume of 1,788 shares, compared to its average volume of 15,620. The stock has a market capitalization of $108.30 million, a PE ratio of 9.58 and a beta of 0.61. Kewaunee Scientific has a 12 month low of $30.33 and a 12 month high of $71.33. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.71 and a current ratio of 2.48. The company’s 50-day moving average is $40.09 and its two-hundred day moving average is $46.98.

Kewaunee Scientific (NASDAQ:KEQU) last posted its earnings results on Wednesday, December 10th. The technology company reported $0.91 EPS for the quarter. Kewaunee Scientific had a return on equity of 22.39% and a net margin of 4.11%.The firm had revenue of $70.10 million during the quarter. During the same quarter in the prior year, the business posted $1.01 earnings per share.

Wall Street Analyst Weigh In

A number of research firms have recently commented on KEQU. Wall Street Zen downgraded shares of Kewaunee Scientific from a “buy” rating to a “hold” rating in a research note on Saturday, December 13th. Weiss Ratings reissued a “hold (c+)” rating on shares of Kewaunee Scientific in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.